Rate My Professor Heidi Staudacher

Staudacher's research examines diet-induced microbiome shifts and the mechanisms through which diet affects the gut and brain, improving management of disorders of gut-brain interaction such as irritable bowel syndrome and common mental disorders including depression. Her team's discoveries demonstrate that the low FODMAP diet shifts the gut microbiome in irritable bowel syndrome, with probiotics mitigating these effects, and have published recommendations for rigorous diet-focused clinical trials. Key publications include "Adherence to a Mediterranean Diet Predicts Gastrointestinal and Anxiety Symptom Response in Irritable Bowel Syndrome" (2026, Clinical Gastroenterology and Hepatology), "A Double-Blind Randomised Controlled Trial of Prebiotic Supplementation in Children with Autism: Effects on Parental Quality of Life, Child Behaviour, Gastrointestinal Symptoms, and the Microbiome" (2025, Journal of Autism and Developmental Disorders), "Co-designing, evaluating and implementing online supportive care for endometriosis in Australia" (2025, BMJ Open), "Cultural competence in the delivery of nutrition and symptom care in irritable bowel syndrome" (2025, The Lancet Gastroenterology & Hepatology), and "FODMAPs and functional dyspepsia: emerging evidence but unanswered questions" (2025, Gut). She contributes to the Rome V DGBI Treatment Trials committee (2021-present), Dietitians Australia Gastroenterology Leadership team (2021-present), and Gastroenterological Society of Australia Luminal Committee (2023-present). Her internationally impactful research informs dietary management practices for gut and mental health conditions.